tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Cash flow

Compare
1,188 Followers

VistaGen Therapeutics Cash Flow

VTGN's free cash flow for Q2 2026 was $-13.82M. For the 2026 fiscal year, VTGN's free cash flow was decreased by $-16.41M and operating cash flow was $-13.76M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -42.10M$ -25.81M$ -49.72M$ -45.26M$ -12.07M
Investing Cash Flow
$ -13.15M$ -61.00K$ -740.00K$ -200.40K$ -275.40K
Financing Cash Flow
$ 3.21M$ 128.40M$ -1.04M$ 10.48M$ 114.10M
End Cash Position
$ 67.13M$ 119.17M$ 16.64M$ 68.14M$ 103.11M
Free Cash Flow
$ -42.29M$ -25.87M$ -49.93M$ -45.46M$ -12.35M
Currency in USD

VistaGen Therapeutics Cash Flow